N. Goldenberg

发表

Is pharmacogenomics our future? Metformin, ovulation and polymorphism of the STK11 gene in polycystic ovary syndrome.

N. Goldenberg, C. Glueck, 2008, Pharmacogenomics.

The contentious nature of gestational diabetes: diet, insulin, glyburide and metformin

N. Goldenberg, C. Glueck, Ping Wang, 2002, Expert opinion on pharmacotherapy.

Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?

N. Goldenberg, C. Glueck, N. Khan, 2009, Metabolism: clinical and experimental.

Changes in weight, papilledema, headache, visual field, and life status in response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia.

K. Golnik, N. Goldenberg, C. Glueck, 2006, Translational research : the journal of laboratory and clinical medicine.

An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia.

N. Goldenberg, C. Glueck, Ping Wang, 2003, Clinica chimica acta; international journal of clinical chemistry.

An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.

N. Goldenberg, C. Glueck, Ping Wang, 2008, Metabolism: clinical and experimental.

Role of growth hormone in regulating lipolysis, proteolysis, and hepatic glucose production during fasting.

J. Horowitz, N. Goldenberg, A. Barkan, 2008, The Journal of clinical endocrinology and metabolism.

Effects of metformin-diet intervention before and throughout pregnancy on obstetric and neonatal outcomes in patients with polycystic ovary syndrome

N. Goldenberg, C. Glueck, Ping Wang, 2013, Current medical research and opinion.

Original article Effects of metformin-diet intervention before and throughout pregnancy on obstetric and neonatal outcomes in patients with polycystic ovary syndrome

N. Goldenberg, C. Glueck, P. Wang, 2013 .

Efficacy, effectiveness and real life goal attainment of statins in managing cardiovascular risk

N. Goldenberg, C. Glueck, 2009, Vascular health and risk management.

Progressively Worsening Premature Coronary Artery Disease: Adding Anticoagulation Stabilizes–Reverses Clinical Symptomatic Disease Progression in Thrombophilic–Atherothrombotic Patients: A Pilot Study

N. Goldenberg, C. Glueck, Ping Wang, 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Associations between Serum 25-hydroxyvitamin D and Lipids, Lipoprotein Cholesterols, and Homocysteine

N. Goldenberg, C. Glueck, Ashwin Kumar, 2016, North American journal of medical sciences.

Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population.

N. Goldenberg, C. Glueck, J. Morrison, 2009, Metabolism: clinical and experimental.

Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss.

N. Goldenberg, C. Glueck, N. Khan, 2009, Translational research : the journal of laboratory and clinical medicine.

Metformin-diet benefits in women with polycystic ovary syndrome in the bottom and top quintiles for insulin resistance.

N. Goldenberg, C. Glueck, Ping Wang, 2005, Metabolism: clinical and experimental.

Amaurosis Fugax: Associations with Heritable Thrombophilia

K. Golnik, N. Goldenberg, C. Glueck, 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia.

K. Golnik, N. Goldenberg, C. Glueck, 2005, The Journal of laboratory and clinical medicine.

Idiopathic Intracranial Hypertension: Associations with Thrombophilia and Hypofibrinolysis in Men

K. Golnik, N. Goldenberg, C. Glueck, 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Pregnancy Loss, Polycystic Ovary Syndrome, Thrombophilia, Hypofibrinolysis, Enoxaparin, Metformin

N. Goldenberg, C. Glueck, Ping Wang, 2004, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin.

N. Goldenberg, C. Glueck, A. Moreira, 2003, Human reproduction.

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin.

N. Goldenberg, C. Glueck, Ping Wang, 2002, Human reproduction.

Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics.

N. Goldenberg, C. Glueck, 2019, Metabolism: clinical and experimental.

Eligibility for alirocumab or evolocumab treatment in 1090 hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dL despite maximal-tolerated LDL-cholesterol-lowering therapy

N. Goldenberg, C. Glueck, Ashwin Kumar, 2017, Vascular health and risk management.

Vitamin D deficiency, myositis–myalgia, and reversible statin intolerance

N. Goldenberg, C. Glueck, N. Khan, 2011, Current medical research and opinion.

Thrombophilia in Klinefelter Syndrome With Deep Venous Thrombosis, Pulmonary Embolism, and Mesenteric Artery Thrombosis on Testosterone Therapy: A Pilot Study

N. Goldenberg, C. Glueck, Ping Wang, 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Factors regulating growth hormone secretion in humans.

N. Goldenberg, A. Barkan, 2007, Endocrinology and metabolism clinics of North America.

T786C Mutation in the Endothelial Nitric Oxide Synthase Gene in Patients With Primary Osteonecrosis.

N. Goldenberg, C. Glueck, Ping Wang, 2017, Orthopedics.

39 OVERWEIGHT, OBESITY, AND EXTREME OBESITY IN 90% OF WOMEN WITH POLYCYSTIC OVARY SYNDROME.

N. Goldenberg, C. Glueck, P. Gartside, 2004, Journal of Investigative Medicine.

Metformin, pre‐eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome

N. Goldenberg, Ping Wang, J. Pranikoff, 2004, Diabetic medicine : a journal of the British Diabetic Association.

The pattern of growth hormone delivery to peripheral tissues determines insulin-like growth factor-1 and lipolytic responses in obese subjects.

J. Horowitz, N. Goldenberg, A. Barkan, 2009, The Journal of clinical endocrinology and metabolism.

Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients.

N. Goldenberg, C. Glueck, Suraj Khanal, 2009, Translational research : the journal of laboratory and clinical medicine.

Case report: primary osteonecrosis associated with thrombophilia-hypofibrinolysis and worsened by testosterone therapy

N. Goldenberg, C. Glueck, M. Jarman, 2017, BMC Hematology.

Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familial thrombophilia.

N. Goldenberg, C. Glueck, M. Gowda, 2011, Translational research : the journal of laboratory and clinical medicine.

Testosterone, Thrombophilia, and Thrombosis

N. Goldenberg, C. Glueck, Ping Wang, 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome.

N. Goldenberg, C. Glueck, Ping Wang, 2003, Metabolism: clinical and experimental.

Polycystic ovary syndrome, the G1691A factor V Leiden mutation, and plasminogen activator inhibitor activity: associations with recurrent pregnancy loss.

N. Goldenberg, C. Glueck, Ping Wang, 2003, Metabolism: clinical and experimental.

Nonarteritic anterior ischemic optic neuropathy: associations with homozygosity for the C677T methylenetetrahydrofolate reductase mutation.

N. Goldenberg, C. Glueck, Ping Wang, 2004, The Journal of laboratory and clinical medicine.

Treatment of pituitary gigantism with the growth hormone receptor antagonist pegvisomant.

B. Degnan, M. Racine, N. Goldenberg, 2008, The Journal of clinical endocrinology and metabolism.

Testosterone Therapy, Thrombophilia, Venous Thromboembolism, and Thrombotic Events

N. Goldenberg, C. Glueck, Ping Wang, 2018, Journal of clinical medicine.

Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study

N. Goldenberg, C. Glueck, Ping Wang, 2017, Lipids in Health and Disease.

Efficacy, safety, Low density lipoprotein cholesterol lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal tolerated cholesterol lowering therapy: a post-commercialization study

N. Goldenberg, C. Glueck, Ping Wang, 2017, Lipids in Health and Disease.

Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center

N. Goldenberg, C. Glueck, Ping Wang, 2016, Lipids in Health and Disease.

Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy

N. Goldenberg, C. Glueck, Ashwin Kumar, 2016, Journal of Investigative Medicine.

Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy.

N. Goldenberg, C. Glueck, Ping Wang, 2004, Human reproduction.

Thromboembolism peaking 3 months after starting testosterone therapy: testosterone–thrombophilia interactions

N. Goldenberg, C. Glueck, Ping Wang, 2017, Journal of Investigative Medicine.

Insulin Resistance and Triglycerides

N. Goldenberg, C. Glueck, J. Morrison, 2009, Journal of Investigative Medicine.

Metformin-Diet Ameliorates Coronary Heart Disease Risk Factors and Facilitates Resumption of Regular Menses in Adolescents with Polycystic Ovary Syndrome

N. Goldenberg, C. Glueck, Ping Wang, 2009, Journal of pediatric endocrinology & metabolism : JPEM.

Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.

N. Goldenberg, C. Glueck, J. Morrison, 2006, Metabolism: clinical and experimental.

Ramifications of Four Concurrent Thrombophilic Mutations and One Hypofibrinolytic Mutation

N. Goldenberg, C. Glueck, Ping Wang, 2004, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation.

N. Goldenberg, C. Glueck, 2008, Minerva ginecologica.

Energy deficit after exercise augments lipid mobilization but does not contribute to the exercise-induced increase in insulin sensitivity.

J. Horowitz, N. Goldenberg, Nicolas D. Knuth, 2010, Journal of applied physiology.

Idiopathic intracranial hypertension: associations with coagulation disorders and polycystic-ovary syndrome.

S. Iyengar, N. Goldenberg, C. Glueck, 2003, The Journal of laboratory and clinical medicine.

Associations of Thrombophilia, Hypofibrinolysis, and Retinal Vein Occlusion

N. Goldenberg, C. Glueck, Ping Wang, 2004, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy.

N. Goldenberg, C. Glueck, Ping Wang, 2004, Human reproduction.

The Long-Term Metabolic Complications of Childhood Obesity

N. Goldenberg, C. Glueck, J. Morrison, 2010 .

Metformin and gestational diabetes

N. Goldenberg, C. Glueck, Ping Wang, 2003, Current diabetes reports.

N. Goldenberg, C. Glueck, Ashwin Kumar, 2016, Lipids in Health and Disease.

Polycystic ovary syndrome and fertility

N. Goldenberg, C. Glueck, 2013 .

Pathognomonic Palmar Crease Xanthomas of Apolipoprotein E2 Homozygosity-Familial Dysbetalipoproteinemia.

N. Goldenberg, C. Glueck, Ping Wang, 2016, JAMA dermatology.

Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study

N. Goldenberg, C. Glueck, Ping Wang, 2017, Lipids in Health and Disease.

exercise-induced increase in insulin sensitivity mobilization but does not contribute to the Energy deficit after exercise augments lipid

Eric C. Freese, Nicholas H. Gist, K. Cureton, 2015 .

Vitamin D deficiency, myositis–myalgia, and reversible statin intolerance

N. Goldenberg, C. Glueck, N. Khan, 2011, Current medical research and opinion.